Crystal modification of rifapentine using different solvents

Frontiers of Chemical Engineering in China

Volumn 4, Issue 1, 2010, Pages 65-69

  Zhou, Kun ^a   Li, Jun ^a   Luo, Jianhong ^a   Zheng, Dongsheng ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Physicochemical characterization; Recrystallization; Rifapentine

Indexed keywords

EID: 77952886096     PISSN: 16737369     EISSN: 16737474     Source Type: Journal    
DOI: 10.1007/s11705-009-0302-6     Document Type: Article

References (13)

1. Kapoor A, Majumdar D K, Yadav, M R. Crystal forms of nimesulide-asulfonanilide (non-steriodal anti inflammatory drug). Indian J Chem, 1988, 37B: 572-575.
2. Shekunov B Y, Grant D J W, Latham R J, Sherwood J N. In situ optical interferometric studies of the growth and dissolution behavior of paracetamol (acetaminophen) crystals. 3: Influence of growth in the presence of p-acetoxyacetanilide. J Phys Chem, 1997, B101: 9107-9112.
3. Nokhodchi A, Bolourtchian N, Dinarvand R. Crystal modification of phenytoin using different solvents and crystallization conditions. Int J Pharm, 2003, 250: 85-97.
4. Adhiyaman R, Basu S K. Crystal modification of dipyridamole using different solvents and crystallization conditions. Int J Pharm, 2006, 321: 27-34.
5. Finnie S, Ristic R I, Sherwood J N, Zikic A M. Characterisation of growth behaviour of small paracetamol crystals grown from pure solutions. Chem Eng Res Design (Trans IChemE), 1996, A74: 835-838.
6. Chen J X, Wang J K, Zhang Y, Wu H, Chen W, Guo Z C. Crystal growth, structure and morphology of hydrocortisone methanol solvate. J Crystal Growth, 2004, 265: 266-273.
7. Prasad K V R, Ristic R I, Sheen D B, Sherwood J N. Crystallization of paracetamol from solution in the presence and absence of impurity. Int J Pharm, 2001, 215: 29-24.
8. Chow A H L, Grant D J W. Modification of acetaminophen crystals. III: Influence of initial supersaturation during solution-phase growth on crystal properties in the presence and absence of p-acetoxyacetanilide. Int J Pharm, 1988, 42: 123-133.
9. Zhou K, Li J, Ren Y S. Solubility of rifapentine in different organic solvents. J Chem Eng Data, 2008, 53: 998-999.
10. Zhou K, Li J, Zheng D S. Solubility of rifapentine in the binary system of acetic acid and n-octanol solvent mixtures. J Chem Eng Data, 2008, 53: 1978-1979.
11. Nie Q, Wang J K, Wang Y L, Bao Y. Effects of solvent and impurity on crystal habit Modification of 11α-Hydroxy-16α, 17α-epoxyprogesterone. Chin J Chem Eng, 2007, 15: 648-653.
12. Hassan M A, Salem M S, Sueliman M S, Najib N M. Characterization of famotidine polymorphic forms. Int J Pharm, 1997, 149: 227-232.
13. Dalton J T, Straughn A B, Dickason D A, Grandolfi G P. Predictive ability of level A in vitro-in vivo correlation for ringcap controlled-release acetaminophen tablets. Pharm Res, 2001, 18: 1729-1734.